1. HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG
    Chuan-dong Cheng et al, 2020, Pathology - Research and Practice CrossRef
  2. The clinicopathological and prognostic value of Nanog in human gastrointestinal luminal cancer: A meta-analysis
    Chaojie Liang et al, 2018, International Journal of Surgery CrossRef
  3. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis
    Chaojie Liang et al, 2018, Clinica Chimica Acta CrossRef
  4. Stem cell transcription factor NANOG in cancers – is eternal youth a curse?
    Oscar GW Wong et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
  5. SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: Anin vitroand vivo study
    Xue-feng Yang et al, 2017, Oncotarget CrossRef
  6. Spastin Promotes the Migration and Invasion Capability of T98G Glioblastoma Cells by Interacting with Pin1 through Its Microtubule-Binding Domain
    Benan Temizci et al, 2023, Cells CrossRef
  7. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma
    Lupin Jiang et al, 2016, Oncotarget CrossRef
  8. The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis
    Wei Cheng et al, 2018, BioMed Research International CrossRef
  9. Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: Improving the safety of iPS cell transplantation to myocardium
    Lan Zhang et al, 2014, Cell Cycle CrossRef
  10. Regulation of stem cell function by protein ubiquitylation
    Alexandros Strikoudis et al, 2014, EMBO reports CrossRef
  11. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
    Malak Hassn Mesrati et al, 2020, Cells CrossRef
  12. Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44+CD133+ Tumor-Initiating Caco-2 Cells In Vitro and In Vivo
    Junghoon Kim et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  13. Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis
    Jian Wang et al, 2017, Oncology Reports CrossRef
  14. Deregulated proliferation and differentiation in brain tumors
    Fredrik J. Swartling et al, 2015, Cell and Tissue Research CrossRef
  15. Knockdown of the prolyl isomerase Pin1 inhibits Hep-2 cell growth, migration, and invasion by targeting the β-catenin signaling pathway
    Guoliang Fan et al, 2018, Biochemistry and Cell Biology CrossRef
  16. Enhancing Photothermal Therapy Efficacy by In Situ Self-Assembly in Glioma
    Wenyu Song et al, 2023, ACS Applied Materials & Interfaces CrossRef
  17. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction
    Hajar Alemohammad et al, 2020, Life Sciences CrossRef
  18. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer
    Stefano Stifani, 2018, Biomolecules CrossRef
  19. ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
    Ji‐cheng Wu et al, 2018, Cancer Medicine CrossRef
  20. Prognostic value of peptidyl-prolyl cis–trans isomerase 1 (PIN1) in human malignant tumors
    S. G. Khoei et al, 2020, Clinical and Translational Oncology CrossRef